In double-blind phase: treatment with tofacitinib or placebo in 1:1 ratio
📊
Treatment Reviews
See user reviews and ratings for In double-blind phase: treatment with tofacitinib or placebo in 1:1 ratio
🔬
Mega-Study
See real-world data analysis for In double-blind phase: treatment with tofacitinib or placebo in 1:1 ratio
📚
Meta-Analysis
See a meta-analysis of all available research
🔍
Clinical Trials
See clinical trials related to In double-blind phase: treatment with tofacitinib or placebo in 1:1 ratio